Senior Associate Scientist – CMC, Early-Stage Drug Product Development
Sanofi
About this role
A Senior Associate Scientist on Sanofi’s Early-Stage Drug Product Development team supporting the advancement of biologic drug candidates from lead selection through Phase 1 clinical dosage forms. The role is focused on developing patient-centric, high-concentration liquid formulations and driving innovation at the intersection of protein and formulation science. Based in Framingham, MA within the Biologics Drug Product Development & Manufacturing organization.
Skills
Qualifications
About Sanofi
sanofi.comSanofi is a research & development-driven, AI-powered healthcare biopharma company committed to improving lives through innovative medicines & vaccines.
Recent company news
MarketBeatSanofi (NASDAQ:SNY) Hits New 52-Week Low - Should You Sell?
21 hours ago
The Pharma LetterAlchemab Therapeutics lures Sanofi exec to be its CBO
2 days ago
Seeking AlphaSanofi: An Undervalued Stock For Long-Term Dividend Growth Investors (SNY)
2 days ago
SanofiNANOBODY® Technology Platform
Aug 26, 2025
Simply Wall StIs Sanofi (ENXTPA:SAN) Now An Opportunity After A 25.8% One Year Share Price Slide?
3 days ago
About Sanofi
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Sanofi.
Salary
$75k – $108k
per year
More jobs at Sanofi
Similar Jobs
Scientist, Formulation Development
Integrated Resources INC
Associate Scientist II, Biologics Drug Product Development
AbbVie
2026 Biologics Drug Product Development Intern (PhD)
AbbVie
Scientist I, Biologics Drug Product Development
AbbVie
Scientist, Early Stage Formulation
AstraZeneca
Senior Scientist II, Biologics Drug Product Development
AbbVie